The Nutshell

» disease/medicine, policy and funding

Daily News Roundup

Most Recent

image: Different Alcoholic Drinks Tied to Different Moods

Different Alcoholic Drinks Tied to Different Moods

By | November 22, 2017

An online survey finds that people report feeling most relaxed with a glass of red wine or beer, and most aggressive when drinking spirits.

0 Comments

An analysis of President Trump’s proposed $7.2 billion slash to the National Institutes of Health budget points to dire consequences for the development of novel drugs.

0 Comments

The former chief of Eli Lilly USA is picked to replace Tom Price, who stepped down in September amid a controversy over the abuse of taxpayer-funded travel.

0 Comments

Agriculture faculty members allege funding from industry organizations is tied to their employment status.

0 Comments

image: Republican Tax Plan Eliminates Popular Education Exemptions

Republican Tax Plan Eliminates Popular Education Exemptions

By | November 6, 2017

The proposal draws criticism from higher-education groups.

0 Comments

Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.

1 Comment

image: <em>Oncotarget</em> Journal Cut from Medline

Oncotarget Journal Cut from Medline

By | October 26, 2017

New papers from a cancer journal once named as a possibly predatory publication will no longer appear in the widely used research database.

0 Comments

image: Anger Flares over EPA’s Perceived Science Censorship 

Anger Flares over EPA’s Perceived Science Censorship 

By | October 24, 2017

Protests are sparking over the Trump Administration’s latest move to silence a discussion around climate change. 

3 Comments

image: Compound Found in Red Wine Boosts Immune Cell Function

Compound Found in Red Wine Boosts Immune Cell Function

By | October 17, 2017

At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling. 

0 Comments

Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.

3 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Immune Checkpoint Found Lacking in Type 1 Diabetes
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech